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Progressive loss of lung function resulting from the inflammatory response to bacterial colonization is the
leading cause of mortality in cystic fibrosis (CF) patients. A greater understanding of these bacterial infections
is needed to improve lung disease management. As culture-based diagnoses are associated with fundamental
drawbacks, we used terminal restriction fragment (T-RF) length polymorphism profiling and 16S rRNA clone
data to characterize, without prior cultivation, the bacterial community in 71 sputa from 34 adult CF patients.
Nineteen species from 15 genera were identified in 53 16S rRNA clones from three patients. Of these, 15 species
have not previously been reported in CF lung infections and many were species requiring strict anaerobic
conditions for growth. The species richness and evenness were determined from the T-RF length and volume
for the 71 profiles. Species richness was on average 13.3  7.9 per sample and 13.4  6.7 per patient. On
average, the T-RF bands of the lowest and highest volumes represented 0.6 and 59.2% of the total volume in
each profile, respectively. The second through fifth most dominant T-RF bands represented 15.3, 7.5, 4.7, and
2.8% of the total profile volume, respectively. On average, the remaining T-RF bands represented 10.2% of the
total profile volume. The T-RF band corresponding to Pseudomonas aeruginosa had the highest volume in 61.1%
of the samples. However, 18 other T-RF band lengths were dominant in at least one sample. In conclusion, this
reveals the enormous complexity of bacteria within the CF lung. Although their significance is yet to be
determined, these findings alter our perception of CF lung infections.
The average life expectancy of patients with cystic fibrosis
(CF) has increased greatly over the past 50 years (20), with the
introduction of antibiotic therapy to treat bacterial lung infec-
tions being arguably the most important factor in increasing
longevity. Despite these advances, progressive loss of lung
function remains the cause of mortality in 90% of CF patients
(10, 23, 27, 31). The loss of function in the CF lung stems from
damage caused by the intense host inflammatory response to
bacteria that colonize the lung over the lifetime of the patient
(22, 31). Since patients continue to deteriorate despite seem-
ingly appropriate antibiotic therapy, it is important to deter-
mine the nature of the interactions between bacteria and the
CF lung. Such understanding will facilitate improvements in
therapeutic strategies. The first step in this process is, there-
fore, to determine accurately what bacteria are present at a
given time point in the CF lung.
In traditional diagnostic microbiology, the characterization
of the bacteria present within clinical samples requires the
prior culture of bacterial species on selective media (37). How-
ever, the use of selective media and growth conditions requires
assumptions to be made regarding which species will be pres-
ent. Therefore, CF sputa are assayed routinely for only a lim-
ited number of bacterial species considered important, includ-
ing Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus
influenzae, and Burkholderia cepacia complex (16). All such
traditional microbiological techniques are subject to culture
bias. Culture media are capable of supporting the in vitro
growth of only a small fraction of the total range of bacterial
species present (13). The implication of this is that ecological
inferences based on the phenotypic characteristics of cultivated
bacteria are, by their nature, unrepresentative of the natural
populations from which they were obtained (33). In addition, a
significant period of time is required for such traditional cul-
ture-based approaches to yield data.
Recently, terminal restriction fragment length polymor-
phism (T-RFLP) profiling has been used to study the bacterial
diversity within clinical specimens provided by a relatively
small number (n  14) of CF patients (34). While the use of
T-RFLP to characterize the diversity of bacterial communities
from many environments has become common (7, 24, 34, 38),
it has not been applied widely to the study of human infections.
In T-RFLP, nucleic acids are extracted directly from clinical
samples. Phylogenetically informative rRNA gene PCR prod-
ucts, specific for the domain Bacteria, are amplified from these
nucleic acid extracts. Following digestion with a specific restric-
tion endonuclease, ribosomal gene fragments are separated by
gel electrophoresis, forming a T-RFLP profile of the diversity
of the bacterial community within the original sample in a
single electrophoretic lane. Studies have previously shown T-
RFLP to be both reproducible and effective at characterizing
bacterial diversity in CF sputum and bronchoalveolar lavage
samples (34). It is important to note that expectorated sputum
provides an accurate measure of infection and inflammation in
the lower airways (15, 36), with insignificant levels of oropha-
ryngeal contamination (15).
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Host immune response and antibiotic therapies are among
many factors that are important in determining the character-
istics of CF lung infections. However, we hypothesize that it is
also important to understand bacterial interactions and, more
generally, the bacterial ecology of the CF lung. Two key mea-
sures used to describe the complexity of communities are spe-
cies richness and species evenness. Species richness is a mea-
sure of the number of separate species present in a community
(28). Levels of species richness are influenced both by the
number of bacterial species present and by the frequency at
which those species are retained. Species evenness describes
the relative sizes of species populations within a community
(29). As such, while the level of variation in the number of
different bacterial species present in samples taken from a
group of CF patients is potentially relatively small, the propor-
tion that these different species represent within the commu-
nity may vary significantly from patient to patient. Therefore,
to understand species diversity, the contribution of both spe-
cies richness and species evenness must be considered (25).
The central aim of this investigation was to determine the
composition and diversity of the bacterial communities colo-
nizing the CF lung. This was achieved through the use of
T-RFLP analysis, in conjunction with 16S ribosomal DNA
(rDNA) clone sequence analysis. T-RFLP profile analysis en-
abled comparisons of bacterial community composition, rich-
ness, and evenness to be made between CF patients.
MATERIALS AND METHODS
Clinical samples and DNA extraction. Sputum samples were obtained from
adult CF patients attending the regional Cystic Fibrosis Centre at Southampton
General Hospital. The patient group consisted of 34 individuals, who provided
between 1 and 5 sputum samples between 14 September 2001 and 16 July 2002.
Over this period of time, 24 patients suffered a period of pulmonary exacerbation
and 10 patients remained clinically stable. A variety of oral, intravenous, and
nebulized antibiotics were administered to these patients as dictated by the
clinicians involved in this study. A total of 71 separate CF sputum samples were
collected and processed immediately.
Samples were washed three times in phosphate-buffered saline (Oxoid) prior
to DNA extraction. Samples were then treated with Sputasol (Oxoid) in accor-
dance with the manufacturer’s instructions, followed by centrifugation for 5 min
at 12,000  g. Pellets were resuspended in 1.5 ml of phosphate-buffered saline
and then centrifuged for 5 min at 12,000  g. This step was repeated three times.
DNA was isolated from clinical specimens by a modification of a procedure
described previously (6). Approximately 0.2 ml of each clinical sample was
resuspended in 800 l of 200 mM sodium phosphate buffer (pH 8.0) and 100 l
of guanidinium thiocyanate-EDTA-Sarkosyl. Then, 0.2 g of 0.18-mm-diameter
glass beads (B. Braun Biotech International GmbH, Melsungen, Germany) was
added, and homogenization was performed for 30 s at 30 Hz in a Mixer Mill 300
(Qiagen, Crawley, United Kingdom). Samples were heated to 70°C for 20 min
and then placed on ice for 20 min, and beads and other debris were pelleted by
centrifugation at 12,000 g for 5 min at room temperature. The supernatant was
transferred to a fresh microcentrifuge tube, and NaCl (to a final concentration of
0.5 M) and polyethylene glycol (to a final concentration of 15%) were added.
Samples were left to precipitate at 4°C for 1 h. DNA was pelleted by centrifu-
gation at 12,000  g for 10 min at room temperature, and the pellet was
resuspended in 300 l of sterile distilled water. Next, 0.3 ml of Tris-buffered
phenol (pH 8.0) was added to each sample before the tubes were vortexed
vigorously. After centrifugation at 12,000  g for 5 min, supernatants were
transferred to fresh microcentrifuge tubes. A further 0.3 ml of Tris-buffered
phenol (pH 8.0)–chloroform–isoamyl alcohol (25:24:1) was added, and the mix-
ture was vortexed vigorously. After centrifugation at 12,000  g for 10 min,
supernatants were precipitated by using an equal volume of isopropanol and a
1/10 volume of 10 M ammonium acetate for 1 h at 20°C. The pellets formed by
centrifugation at 12,000  g for 10 min at room temperature were washed three
times in 70% ethanol. After being dried, pellets were resuspended in 100 l of
sterile distilled water and stored at 20°C. The extracted DNA was verified by
Tris-acetate-EDTA–agarose gel electrophoresis.
DNA quantification. Extracted genomic DNA and restricted PCR products
were quantified by use of a CytoFluor series 4000 multiwell plate reader (Per-
Septive Biosystems, Foster City, Calif.) and by using the PicoGreen DS DNA
quantitation kit (Molecular Probes, Leiden, The Netherlands) according to the
manufacturer’s instructions.
PCR amplification and restriction endonuclease digestion. The oligonucleo-
tide primers used to amplify a region of the 16S rRNA gene for members of the
domain Bacteria, 8f700 and 926r (5-CCG TCA ATT CAT TTG AGT TT-3),
were described previously (24). Primer 8f700 was labeled at the 5 end with
IRD700; primer 926r was unlabeled. PCR mixtures comprised 1 PCR buffer,
1.5 mM MgCl2, each deoxynucleoside triphosphate at a concentration of 0.2 mM,
each primer at a concentration of 0.2 mM, and 1 U of REDTaq DNA polymerase
(Sigma-Aldrich) in a final volume of 50 l. An initial denaturation step of 94°C
for 2 min was followed by 32 cycles of denaturation at 94°C for 1 min, annealing
at 56°C for 1 min, and extension at 72°C for 2 min, with a final extension step at
72°C for 10 min. Amplification was carried out by using a GeneAmp PCR System
2400 (Perkin-Elmer), with PCR products for T-RFLP analysis stored at 20°C
after verification on Tris-acetate-EDTA–agarose gels as described above.
PCR products (ca. 20 ng) were digested by using the restriction endonuclease
CfoI (Roche, Lewes, United Kingdom) for 3 h at 37°C with the reaction buffer
supplied by the manufacturer. All restriction endonuclease digestions were car-
ried out to complete digestion as shown by comparing PCR products after
various digestion incubation times (data not shown). The restriction endonucle-
ase was inactivated by heating at 90°C for 20 min. An approximately 0.7-g
portion of T-RFLP PCR products was separated by length by using a 25-cm
SequagelXR denaturing acrylamide gel (National Diagnostics) prepared in ac-
cordance with the manufacturer’s instructions with the addition of 8.3 M urea
and 10% (final concentration) formamide and by using an IR2 automated DNA
sequencer (LI-COR Biosciences) at 55°C and 1,200 V.
T-RFLP profile analysis. Gels were analyzed by using Phoretix one-dimen-
sional advanced software, version 5.10 (Nonlinear Dynamics, Newcastle upon
Tyne, United Kingdom). The sizes of the bands resolved by T-RFLP were
determined by comparing their relative positions with two sets of size markers,
one set that formed bands at 75, 100, 150, 200, 250, 300, 350, 400, 450, 500, 600,
700, 800, 900, and 1,000 bases (microSTEP 15a [700 nm]) and one set that
formed bands at 155, 209, 214, 238, and 364 bases (microSTEP custom GR [700
nm]). Both sets of size markers were obtained from Microzone (Lewes, United
Kingdom). In addition, this software was also used to determine the volume of
each band (with band volume being the product of the area over which a band
was detected and the intensity of signal recorded over that area). Band volume
was expressed as a percentage of the total volume of bands detected in a given
electrophoretic profile. T-RFLP bands were resolved over the region between 50
and 958 bases. No bands shorter than 50 bases in length were recorded, as they
were in the region susceptible to high levels of signal stemming from the IR tag
on either unattached or nonused primer 8f700IR. In this study, the threshold used
to detect bands was 0.01% of the total signal between the 50- and 958-base region.
In silico T-RFLP band size determination. Published bacterial 16S rRNA gene
sequence data stored at GenBank (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi
?db_Nucleotide) were retrieved. MapSort (Wisconsin Package, version 10.3;
Accelrys) was used to predict T-RFLP band sizes by locating the position of a
specific restriction endonuclease recognition motif, here CfoI, in a given se-
quence. T-RFLP band lengths (in bases) were therefore obtained for the region
from the 5 end of primer 8f700IR to the first cleavage position of the restriction
endonuclease CfoI in each 16S rRNA gene sequence. A total of 853 sequences
were analyzed in this way with the data stored at http://www.kcl.ac.uk/kis/schools
/life_sciences/life_sci/TRFLP.html. Of the 853 sequences analyzed, approximate-
ly 10% matched an empirically derived T-RF band length (Table 1).
Preparation and analysis of 16S rDNA clones libraries. PCR products for 16S
rRNA clone analysis were amplified with the universal bacterial primers 8f700
(as described above) and 338r (5-GCT GCC TCC CGT AGG AGT-3) (32)
obtained from MWG-Biotech (Milton Keynes, United Kingdom). The PCR
mixture composition, amplification program parameters, and equipment were all
as described above. Samples of the PCR products generated were cloned with a
pGEM-T Easy Vector system (Promega, Southampton, United Kingdom) ac-
cording to the manufacturer’s instructions. DNA was extracted from clones as
follows: a single white colony was resuspended in 200 l of sterile distilled water
and then boiled for 10 min, with the cell debris pelleted by centrifugation at
12,000  g for 5 min. Then, 15 l of the supernatant was added to a 50-l (final
volume) PCR mixture, comprising 1 PCR buffer, 1.5 mM MgCl2, each deoxy-
nucleoside triphosphate at a concentration of 0.2 mM, each primer at a concen-
tration of 0.2 M, and 1 U of REDTaq DNA polymerase (Sigma-Aldrich) in a










final volume of 50 l. Amplification was carried out with the primers gemsp6
(5-GCT GCG ACT TCA CTA GTG AT-3) and gemt7 (5-GTG GCA GCG
GGA ATT CGA T-3) as previously described (34). The PCR mixture compo-
sition, amplification program parameters, and equipment were all as described
above.
The sequencing of individual clones was carried out by the Genetics Core
Facility, Hammersmith Hospital, London, United Kingdom. Sequences were
analyzed by BLAST (18) and by using the Ribosomal Database Project II (19).
BLAST matches described below all had an e-value greater than e142. Novel
sequence types obtained in this study were stored in GenBank under accession
numbers AJ555128 to AJ555147.
RESULTS
Species identification and relative prevalence. T-RFLP pro-
files were generated for each of the 71 sputum samples studied.
Figure 1 shows a region of the electrophoretic output of a
typical lane and the band size data contained within it being
extracted. By such comparisons, a total of 248 distinct T-RF
band sizes were detected over the sizeable range of the T-
RFLP gel.
The frequency at which each of these 248 different T-RF
bands was detected in the sample set was determined. Detec-
tion frequencies ranged from 1.4% (representing a T-RF band
that was present in a single sample) to 87.5% of samples (the
T-RF band of 155 bases in length). The frequency at which the
T-RF bands were detected in each individual patient was also
determined. Little difference was found between these detec-
tion frequencies and those for the sample set as a whole, with
detection rates ranging from 3% (present in a single patient) to
88%. However, certain T-RF band sizes were confined to a




with band Bacterial species assignation
59 62 Craurococcus roseus
61 44 Rhizobium loti, Ochrobactrum anthropi, Peptostreptococcus anaerobius
68 21 Ralstonia gilardii
92 9 Bilophila wadsworthia
93 3 Desulfovibrio desulfuricans, Tistrella mobilis
96 3 Wolinella succinogenes, Campylobacter rectus, Bacteroides forsythus
98 6 Bacteroides gracilis
102 57 Prevotella loescheii, P. salivae, P. buccae, P. oris, Porphyromonas gingivalis
104 71 Porphyromonas endodontalis, Prevotella denticola, P. melaninogenica, P. nigrescens, P. veroralis, P. intermedia
155 88 Pseudomonas aeruginosa
197 3 Acinetobacter junii
201 9 Mycobacterium tuberculosis
207 15 Acinetobacter johnsonii
208 3 Pandoraea pulmonicola
209 15 Burkholderia cepacia complexb
210 9 Burkholderia gladioli
211 15 Abiotrophia paraadiacens
213 12 Actinomyces viscosus, A. naeslundii, Xanthomonas campestris, Morganella morganii, Neisseria species (N. meningitidis,
N. gonorrhoeae), Xanthomonas hyacinthi, Pseudomonas aureofaciens, Legionella pneumophila
214 9 Stenotrophomonas maltophilia, Fusobacterium gonidiaformans
215 6 Aeromonas caviae, Abiotrophia defectiva
225 6 Flavobacterium indologenes
238 18 Staphylococcus aureus, S. epidermidis, S. cohnii, S. hominis
256 3 Lactobacillus murinus
266 6 Staphylococcus sciuri
279 3 Rhizobium radiobacter
339 3 Methylobacterium radiotolerans
363 6 Mycobacterium chelonae
364 9 Haemophilus paraphrophilus, H. influenzae, Actinobacillus actinomycetemcomitans
367 3 Mycobacterium flavescens
372 15 Salmonella enterica serovar typhimurium, Bifidobacterium pseudocatenulatum, Proteus mirabilis
445 3 Bordetella hinzii
562 6 Eubacterium saburreum
563 6 Halomonas variabilis
566 18 Comamonas testosteroni
569 26 Paracoccus halodenitrificans
571 3 Pseudomonas huttiensis
574 35 Ralstonia pickettii, Oligella urethralis
576 6 Streptococcus pneumoniae, S. salivarius, S. pyogenes, S. macedonicus, S. sanguinis
585 32 Selenomonas sputigena, Streptococcus intermedius
587 6 Peptococcus-like species oral clone JM048
588 9 Veillonella parvula
589 3 Capnocytophaga sputigena
590 3 Streptococcus anginosus, Veillonella atypica, V. ratti
843 3 Alcaligenes xylosoxidans
846 9 Treponema pallidum
a T-RF bands were detected in the sample set, and corresponding species band sizes were predicted (as determined by software-driven analysis of published sequence
data). The percentages of patients in the sample set in which each band was detected and the names of the species with which they are consistent are listed.
b Sequences from genomovars B. cepacia, B. multivorans, B. stabilis, B. vietnamensis, B. ambifaria, and B. anthina of the B. cepacia complex were all subjected to in
silico analysis. However, there was insufficient sequence data to derive in silico T-RFLP band size lengths for genomovars B. dolosa, B. pyrrocinia, B. ubonensisa, or
B. cenocepacia.










relatively small subset of the patient group. For example, the
T-RF band 64 bases in length was detected in 32% of samples
overall but in only 17% of patients (data not shown).
Where possible, individual T-RF bands were assigned to
bacterial species by comparison of band size with in silico band
size predictions made for the range of bacteria, as described in
Materials and Methods. Through this process, 45 (18%) of the
248 different T-RF band sizes resolved in this set of patients
were found to match the band length predicted for one or
more bacterial species in silico (Table 1). Of these 45 matches,
29 corresponded to a single bacterial species from our in silico
data set. Sixteen T-RF band sizes corresponded to several spe-
cies belonging to more than one genus, and four corresponded
to more than one species from within a single genus (Table 1).
It should be noted that the resolution of a band of the length
predicted by in silico analysis for a particular bacterial species
does not indicate the presence of that species but is merely
consistent with the presence of that species.
Species prevalence and identification—16S rRNA gene
clone sequence analysis. Samples from three patients were
selected at random for sequence analysis of 16S rRNA gene
PCR product clone libraries. Clone libraries of 16S rRNA
regions amplified from nucleic acids extracted directly from
sputum samples from these patients were generated. A total of
53 cloned 16S rRNA gene regions were sequenced (20 clones
from each of two patients and 13 clones from the third pa-
tient). 16S rRNA gene sequences generated here were com-
pared to published 16S rRNA sequence data to enable bacte-
rial species identification. A total of 19 bacterial species were
identified within these 53 cloned 16S rRNA regions (Table 2).
Table 2 shows the bacterial species that provided the closest
matches, in terms of sequence similarity, to database entries.
The 19 different bacterial species identified were held within 15
different genera. The phylogenetic diversity of these cloned
sequences was wide, with genus members within the Bacte-
roidetes/Chlorobi group (genera Bacteroides, Porphyromonas,
and Prevotella), the Proteobacteria (genera Burkholderia ,
Ralstonia , and Pseudomonas ), the Firmicutes (genera
Abiotrophia, Eubacterium, Lactobacillus, Mycoplasma, Staphy-
lococcus, Streptococcus, and Veillonella), the Actinobacteria
(genus Mycobacterium), and the Spirochaetes (genus Trepo-
nema).
Species richness and evenness. (i) Richness. The number of
separate T-RF bands resolved in the samples studied ranged
from 2 to 37. A mean of 13.3 (	7.9 [standard deviation])
distinct T-RF bands were detected for each clinical sample
analyzed. Twenty of the 34 patients provided samples on more
than one occasion. The mean number of T-RF bands detected
in samples from each patient was 13.4 (	6.7). On average, the
interval between the highest and lowest levels of species rich-
ness in samples provided by the same person was 9.9 (	8.0).
(ii) Evenness. Band volume refers to the area over which
each T-RF band was detected (above an automatically deter-
mined background level) multiplied by the intensity of the
signal at every given point within it. The volume of every band
detected in the T-RFLP profiles was determined and expressed
FIG. 1. Gel image and band extraction. The figure shows both the trace from a region of an electrophoretic lane that forms the basis of the
band assignment and signal intensity measurement process (upper panel) and the corresponding image from which this trace is derived as it
appears on the automated sequencer output (lower panel).
TABLE 2. Bacterial species identified in the sample set through










1 2 3 Samplecohort
Same
sample
Abiotrophia adiacens 1  
Abiotrophia paraadiacens 1 
Bacteroides gracilis 1  
Burkholderia cepacia complex 2  
Eubacterium brachy 1
Lactobacillus crispatus/L. gasseri 2 
Mycoplasma salivarium 2
Porphyromonas sp. 1  
Prevotella melaninogenica 1 4 
Prevotella salivae 1  
Prevotella sp. oral clone 2  
Pseudomonas aeruginosa 1   
Ralstonia taiwanensis 1
Rothia mucilaginosa 3
Staphylococcus hominis 1  
Streptococcus anginosus 18 
Streptococcus pneumoniae/mitis 3 4  / 
Treponema vincentii 2
Veillonella atypica 1 
a Bacterial species detected by 16S rDNA clone analysis. The number of clones
of each species detected is shown. All of the identifications were made based on
matches to published sequence data (see Materials and Methods).










as a percentage of the total volume of a given profile (data not
shown). On average, the smallest T-RF band volume detected
in a profile was 0.6%, although in one instance it was as low as
0.012%.
The bands detected in each profile were placed in rank order
of descending volume. This order of descending band volume
was referred to as the order of dominance. Mean volumes for
bands occupying each position in the order were then deter-
mined for the sample set as a whole. These mean volumes are
represented in Fig. 2. It was found that the volume of the most
dominant band was, on average, approximately four times as
great as that of the second most dominant band (59.2 and 15.3%,
respectively). The second most dominant band was found to be
approximately twice the volume of the third (15.3% compared
with 7.5%, respectively), with the fourth and fifth most domi-
nant T-RF mean band volumes representing 4.7 and 2.8%,
respectively. The majority of T-RF bands represented less than
1% of the total band volume. Outside of the five most domi-
nant T-RF bands, the subtotal of mean band volumes together
represented only 10.2% of the overall lane volume.
The number of times a T-RF band occupies the dominant,
second, third, fourth, or fifth position in a profile was deter-
mined (data not shown). Further, the percentage of samples in
which the band was detected at this position in the dominance
hierarchy and the percentage of samples in which it was de-
tected were determined. The T-RF band size of 155 bases,
corresponding to that predicted for P. aeruginosa, had the high-
est band volume in the majority of samples (61.1%). However,
when not the dominant T-RF band, the 155-base fragment was
relatively rarely detected in one of the other top five ranked
positions (Table 3). In total, 18 non-155 T-RF band sizes were
the highest-volume band in at least one of the 71 profiles ex-
amined. A total of 79 different T-RF band sizes occupied one
of the five highest-volume bands in at least one profile.
The dominance of T-RF band sizes corresponding to four
other bacterial species (B. cepacia complex at 209 bases, Ste-
notrophomonas maltophilia at 214 bases, S. aureus at 238 bases,
and H. influenzae at 364 bases) traditionally considered to be
key CF pathogens were also assessed (Table 3). It should be
noted that, in the case of S. aureus and the B. cepacia complex,
several species from the same genus produce T-RF bands of
the same length, and in the case of H. influenzae and S. malto-
philia, species from other genera produce identical band
lengths (34). Therefore, it is possible that the dominance at-
tributed to these species may be contributed to by other, in
some cases unrelated, species. Further, in the case of B. cepa-
cia complex, the species B. cepacia, Burkholderia multivorans,
Burkholderia stabilis, Burkholderia vietnamensis, Burkholderia
ambifaria, and Burkholderia anthina all have identical in silico
T-RFLP band sizes (209 bases); however, there is currently
insufficient sequence data to derive in silico T-RFLP band size
lengths for the species Burkholderia dolosa, Burkholderia pyr-
rocinia, Burkholderia ubonensisa, or Burkholderia cenocepacia.
No T-RF band representing a non-key species was detected
in any top five dominance position in more than 8.3% of the
profiles. On average, such bands were detected in 2.3% of the
profiles. A number of species were present in a large propor-
tion of profiles but only as bands of low relative volume. These
included bands of 585, 268, 203, and 580 bases in length de-
tected in 33, 30, 27, and 27% of patients, respectively. The
assignment of a bacterial species on the basis of in silico length
prediction was possible in the case of only one of these band
sizes, namely the T-RF band of 585 bases in size to either
Streptococcus intermedius or Selenomonas sputigena.
DISCUSSION
The findings of this study change our understanding of the
diversity of bacteria present in the respiratory tract of CF
patients. This knowledge is crucial if the management of re-
spiratory infections, a major determinant of prognosis, is to be
improved. Two related approaches were used to characterize
the diversity of the bacteria in sputum samples from a group of
34 patients attending a regional adult CF clinic in Southamp-
ton, England. Sequence analysis of cloned 16S rRNA gene
PCR products enabled the identification of bacteria from a
subset of these patients. However, such analysis of clone library
FIG. 2. Graph of mean percentage of total band volume represented by rank-ordered T-RF bands.
TABLE 3. Dominance of key CF pathogens in profiles
generated from data seta
Species
% of samples in which species had
dominance rank of:
1 2 3 4 5
P. aeruginosa 61.1 0 1.4 1.0 0
S. aureus 5.6 1.4 1.4 0 1.0
B. cepacia complex 1.4 1.4 1.4 0 2.0
S. maltophilia 4.2 0 2.8 0 0
H. influenzae 1.4 7.0 1.4 3.0 2.0
Other 26.3 90.2 91.6 96 95
a Percentages of samples in which a T-RF band consistent with each of the five
key recognized CF pathogens was detected at a given point in the dominance
hierarchy. In addition, the percentage of samples where a T-RF band of a length
not consistent with any of these species occupies a top five dominance position
is shown.










data allows the characterization of only a very small fraction of
the bacteria present in such samples. T-RFLP profiling was
therefore used to examine the diversity of the dominant bac-
terial community members in each of these CF patients. The
resulting data provided information on the levels of bacterial
species richness and evenness in these samples.
Prior to this study, there was little appreciation of the num-
ber of bacterial species present in CF sputum. This study has
shown that, typically, individual CF patients were colonized by
many different species. These species spanned a wide range of
bacterial growth strategies with respect to oxygen, with aer-
obes, facultative anaerobes, and obligate anaerobes all de-
tected in this group of patients. Further, many of the species
identified here have not previously been reported in CF lung
infections. These findings are highly significant because they
reveal the complexity of CF lung bacterial ecology. Moreover,
they demonstrate the inadequacy of community analysis car-
ried out with traditional culture-based techniques. This study
highlights a gap in our understanding of the mechanisms in-
volved in CF lung infections and underlines the importance of
the application of molecular microbial ecology to the analysis
of complex bacterial infections in general.
Sputum samples from CF patients were carefully washed to
remove saliva and bacteria that adhered to the bolus during its
passage through the upper airways and mouth. Despite these
careful attempts, it is important to acknowledge the possibility
that oropharyngeal contamination could contribute to the di-
versity of the species identified in this study. Certain species
were detected that are associated typically as flora found in the
oral cavity or upper respiratory tract. However, these T-RF
bands may represent species that have genuinely colonized the
CF lung, as there is both a very low level of saliva carryover
from CF sputa and a high bacterial load in the sputum itself.
The analysis of cloned 16S rRNA sequences is an important
tool in identifying the bacterial species present in a given
sample. Data derived through this process confirmed the pres-
ence of five bacterial species whose corresponding T-RF bands
were detected in the sample group (B. cepacia complex, B. mul-
tivorans, Rhodotorula mucilaginosa, P. aeruginosa, Streptococ-
cus pneumoniae, and Streptococcus mitis). In addition, clone
analysis identified 14 species not previously reported in CF
lung infections (Abiotrophia adiacens, Abiotrophia paraadia-
cens, Bacteroides gracilis, Eubacterium brachy, Mycobacterium
mucilaginosus, Mycoplasma salivarium, Porphyromonas salivae,
Prevotella melaninogenica, Prevotella sp. oral clone, Ralstonia
taiwanensis, Staphylococcus hominis, Streptococcus anginosus,
Treponema vincentii, and Veillonella atypica) (Table 2). This
group included five facultative anaerobic species (A. adiacens,
A. paraadiacens, R. taiwanensis, S. hominis, and S. anginosus)
and eight obligate anaerobic species (B. gracilis, E. brachy,
M. salivarium, Porphyromonas sp., P. salivae, P. melaninogenica,
Prevotella sp. oral clone, and V. atypica). The presence of these
species is consistent with previous studies that found that the
CF lung has anaerobic regions (41). This is potentially clini-
cally relevant, as anaerobic species have only recently been
implicated in CF lung infections and are not targeted by many
current antibacterial treatments.
Comparison of the species detected in this sample set with
those previously detected in 103 clones obtained from five
adult CF patients (34) reveals both similarities and differences
between the two sets of patients. Although only one of the 29
species detected in the two studies was found in patients within
both cohorts (P. aeruginosa), in both cases, relatively large
proportions of the species detected were anaerobes or species
not previously reported in CF lung infections (Table 2). It is
important to note that bias can be introduced at the cloning
stage of this process and can have a significant impact on the
data derived (40). In addition, analysis of clone libraries is a
relatively inefficient and expensive process that typically re-
quires the examination of large numbers of clones to obtain
detailed ecological information from a sample. Moreover, it is
highly labor intensive and, as such, is unsuitable for the analysis
of a set of samples taken from a large patient group.
T-RFLP profiling, however, is well suited to the analysis of
large groups of samples. In this study, attempts were made to
link T-RF band lengths with particular bacterial species on the
basis of predictions made by using published sequence data.
This process, described previously (34), encompassed more
than 160 bacterial species associated with a wide range of en-
vironments. In the process of assigning T-RFs to particular
bacterial species, it should be noted that the quality of the
sequence data used influences the accuracy of the linkage
made. As more sequence data become available, however,
such linkages will become more robust. Through this analysis,
around 20% of the T-RF band lengths resolved in the sample
set were assigned to at least one bacterial species. As this
process affords no direct verification of species assignation,
these data were compared to the 16S rDNA clone analysis
data. This is an iterative process, and the proportion of T-RF
bands that have corresponding species predictions will increase
as further clone analysis of CF sputum samples is performed.
The mean species richness for the samples group was 13.3
(	7.9). To put this in context, soil communities typically have
a minimum of 4,000 to 7,000 different bacterial genomes per
gram (39). Also at the high end of reported species richness
levels are certain areas of the human body. For example, the
gut is estimated to contain between 400 and 500 different
bacterial species (26). In the gastrointestinal tract, the pres-
ence of this diverse array of species is not typically associated
with deleterious health effects to the host. Chronic sinusitis is
an example of an infectious disease that results from the pres-
ence of multiple bacterial species. Culture-based studies have
shown that such infections typically involve around three sep-
arate bacterial species (5). At the other end of the spectrum of
species richness, many types of bacterial infection involve a
single species (4, 14). Therefore, the levels of species richness
reported here in CF sputa were between these two extremes.
However, the data indicate that there is diverse and complex
polymicrobial infection in an area of the body that has been
considered to be sterile under normal circumstances in healthy
individuals (11, 35). In a very-small-scale pilot study of samples
obtained from healthy individuals through induced expectora-
tion, we have obtained data that challenge this concept (data
not shown). However, interestingly, little or no overlap was
found between the bacterial community banding profiles ob-
tained for healthy individuals and those obtained from CF
patients.
The mean species richness found in individual patients was
almost identical to that for the sample set as a whole (13.4 	
6.7), suggesting that species richness is relatively consistent










between patients. This relative lack of variation suggests that
the level of species richness found in the CF lung may reflect
certain facets of this environment. However, despite consis-
tency in levels of species richness between patients, the varia-
tion found between samples taken from particular patients was
relatively high (a mean variation of 9.9 	 8.0). This fluctuation
suggests that the bacterial community present in the CF lung is
dynamic and may show marked changes over relatively short
time intervals. These changes may reflect such factors as the
onset of pulmonary infective exacerbation or antibacterial
therapy. In the longer term, they may provide a useful clinical
tool for the prediction and quantification of pulmonary infec-
tive exacerbations.
The level of species richness for the sample set as a whole
was relatively high, with 248 distinct T-RF band lengths re-
solved. This is particularly significant, since the number of
bacterial species that have previously been reported in CF lung
infections is relatively small (8). The identification of the spe-
cies that these T-RF bands represent could have dramatic
implications for the way in which CF is viewed and treated and
therefore represents another important area for future re-
search.
The relative signal intensity (band volume) was determined
for every T-RF band detected in the sample set. These band
volumes were used to provide a measure of relative species
prevalence. However, it should be noted that there are other
factors apart from the number of organisms of each species
present in the sample that can affect relative band volumes.
Chief among these is variation in the ribosomal operon copy
number between different bacterial species. The range of copy
numbers is potentially relatively high. For example, Rickettsia
prowazekii and Mycoplasma pneumoniae possess only one ri-
bosomal operon (1, 3), whereas Clostridium paradoxum has 15
ribosomal operon copies per genome (30). However, the num-
ber of genomes in the majority of species is likely to cluster
within a much narrower range.
In previous studies, it has been shown that, in T-RFLP
profiles generated from model DNA mixtures composed of
different pure cultures, the intensity of the signal representing
each species was proportional to the number of ribosomal
operon copies possessed by that species (17). Unfortunately, it
was not possible to take ribosomal operon copy number into
account when interpreting band volume data for two reasons.
As indicated above, the majority of T-RF bands detected in
these samples are yet to be identified. Moreover, data relating
to the number of ribosomal operons possessed by different
species, including relatively well-characterized species, are of-
ten scarce. However, the volumes of many of the T-RF bands
resolved in this study differed by more than an order of mag-
nitude. Further, in many cases, dominant T-RF bands corre-
sponded to species known to have a relatively low operon copy
number. It was, therefore, felt that a cautious interpretation of
relative species prevalence could be made.
Although the bacterial communities present in CF sputa
were shown here to be relatively diverse, the total band volume
detected in a profile was not distributed evenly between its
constituent species. Instead, in the majority of cases, a single
species was dominant, typically representing 59.2% (	21.3%)
of the total lane volume, with the next most dominant species
representing 15.3% (	8.3%). The fact that 19 different species
occupied this dominant position within the 71 samples ana-
lyzed suggests strongly that this is not merely due to their pos-
session of a higher than average ribosomal operon copy num-
ber.
Significantly, in 28% of samples, the numerically dominant
T-RF band corresponded to a bacterial species not tradition-
ally considered to be clinically significant in CF lung infections.
For example, in 4.2% of samples, a 574-base T-RF band had
the highest band volume. This band length corresponded with
that predicted for two different species, Ralstonia pickettii and
Oligella urethralis. Of these, only R. pickettii has previously been
reported in the respiratory secretions of CF patients (9). How-
ever, regardless of whether such species exhibit pathogenic
behavior, their presence in the lung at such high levels is likely
to be clinically relevant, for example, because they elicit an
immune response. Moreover, their presence in the bacterial
community may affect other bacterial species through both
positive and negative interaction.
In addition, the presence, at a relatively low prevalence, of
a wide range of bacterial species not traditionally associated
with CF lung infection may be equally significant. In some in-
stances, such species were only detected in a small number of
patients and may represent chance infections by opportunistic
pathogens able to establish themselves in large numbers once
within the lung. An example is the 92-base T-RF band, corre-
sponding to the size predicted for Bilophila wadsworthia. This
is a species associated with appendicitis, abscesses, bacteremia,
and biliary tract sepsis (21) which has also been reported to be
present in the gastrointestinal tract (2). It is tempting to spec-
ulate whether the presence of this species in the CF lung may
be related to gastric aspiration induced by strenuous coughing.
In other cases, however, these species were detected in a
high proportion of individuals. For example, a 104-base T-RF
band, corresponding to the predictions made for a number of
different Prevotella species, was resolved in 47.2% of patients
on at least one occasion. The presence of such species may be
significant for several reasons. First, some may be highly patho-
genic and have an impact on patient health that is dispropor-
tionate to their numbers. Second, the presence of these species
may support the colonization of the lung by other, potentially
more virulent, organisms. This emphasizes the requirement of
considering the bacteria colonizing the CF lung to be part of a
complex community, the dynamics of which are, in part, deter-
mined by the interactions of the species within it. Consequent-
ly, this has an impact on the way in which specific therapeutic
agents should be administered against such a community.
The enormous complexity of bacterial species within the CF
lung that is described here has a significant impact on the way
we think about the pathogenesis of CF lung infections. The full
significance of these findings has yet to be determined, al-
though these previously unreported species may be important.
While many questions remain unanswered, it is likely that
these new species affect the host in a number of ways. The
direct impacts on the host, such as severe pulmonary infection,
are obvious. However, these species may also play important
roles in the exuberant, immune-mediated, inflammatory cas-
cade that is elicited by the presence of bacteria in CF patients.
Moreover, the interaction of these species with the traditional
pathogens may well involve both positive and negative feed-
back mechanisms, which determine the frequency and severity










of CF infective exacerbations. For example, studies with ani-
mal models have shown that P. aeruginosa pathogenicity is
significantly increased in the presence of avirulent, oropharyn-
geal flora (12). Further investigation is now required to docu-
ment temporal changes in bacterial profiles generated from
individual patients to correlate these variations with clinical
parameters. Such a study will help to improve our understand-
ing of the inadequacies of present antibiotic therapies and
allow us to improve our management of infective episodes.
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